Citations

Clear

17 citation(s) found for "Shah, Samir".

Anesthesia and Critical Care for the Prediction and Prevention for Small-for-size Syndrome: Guidelines from the ILTS-iLDLT-LTSI Consensus Conference
Rajakumar, Akila , Shingina, Alexandra , Yoon, Uzung , Patel, Dhupal , Spiro, Michael , Bhangui, Pooja , Sun, Li-Ying, Humar, Abhinav , Findlay, James Y. , Saigal, Sanjiv , Rodríguez-Dávalos, Manuel I. , Kumar, Lakshmi , Kumaran, Vinay , Agarwal, Shaleen , Egawa, Hiroto , Lerut, Jan , Bröering, Dieter C. , Berenguer, Marina , Cattral, Mark S. , Clavien, Pierre‐Alain , Chen, Chao‐Long , Shah, Samir, Zhu, Zhi‐Jun , Ascher, Nancy L. , Emond, Jean C. , Rela, Mohamed , Findlay, James, Berenguer, Marina , Chadha, Ryan , Sakai, Tetsuro , Bezinover, Dmitri , Singh, Shweta A , Yi, Nam‐Joon , Berlakovich, Gabriela , Bhangui, Prashant , Rammohan, Ashwin

Mayo Clinic

Transplantation | September 26, 2023 | Volume: 107 | Issue: 10 | Pages: 2216-2225

10.1097/tp.0000000000004803 | PMID 37749811 Get It

Background. During the perioperative period of living donor liver transplantation, anesthesiologists and intensivists may encounter patients in receipt of small grafts that puts them at risk of developing small for size syndrome (SFSS). Methods. A scientific committee (106 members from 21 countries) performed an extensive literature review on aspects of SFSS with proposed recommendations. Recommendations underwent a blinded review by an independent expert panel and discussion/voting on the recommendations occurred at a consensus conference organized by the International Liver Transplantation Society, International Living Donor Liver Transplantation Group, and Liver Transplantation Society of India. Results. It was determined that centers with experience in living donor liver transplantation should utilize potential small for size grafts. Higher risk recipients with sarcopenia, cardiopulmonary, and renal dysfunction should receive small for size grafts with caution. In the intraoperative phase, a restrictive fluid strategy should be considered along with routine use of cardiac output monitoring, as well as use of pharmacologic portal flow modulation when appropriate. Postoperatively, these patients can be considered for enhanced recovery and should receive proactive monitoring for SFSS, nutrition optimization, infection prevention, and consideration for early renal replacement therapy for avoidance of graft congestion. Conclusions. Our recommendations provide a framework for the optimal anesthetic and critical care management in the perioperative period for patients with grafts that put them at risk of developing SFSS. There is a significant limitation in the level of evidence for most recommendations. This statement aims to provide guidance for future research in the perioperative management of SFSS.
Baseline Clinical Factors Are Associated With Risk of Complications in Crohn's Disease: Appraisal of the American Gastroenterological Association Clinical Care Pathway
Santiago, Priscila , Lennon, Ryan J. , Rui, Shumin, Rajauria, Palak , Friton, Jessica, Raffals, Laura E. , Deepali, Fnu , Daoud, Nader , Farraye, Francis A. , Tuck, Jaclyn , Shapiro, Jason M. , Shah, Samir A. , Lennon, Ryan J , Rajauria, Palak , Farraye, Francis A , Malik, Talha , Leleiko, Neal S , Shapiro, Jason , Shah, Samir A , Sands, Bruce E , Coelho–Prabhu, Nayantara , Malik, Talha A. , LeLeiko, Neal S. , Ungaro, Ryan C.

Mayo Clinic

American Journal of Gastroenterology | September 15, 2023 | Volume: 119 | Issue: 1 | Pages: 147-154

10.14309/ajg.0000000000002498 | PMID 37713528 Get It

INTRODUCTION: The American Gastroenterological Association (AGA) has compiled risk factors that may be predictive of disease complications in Crohn's disease (CD) and ulcerative colitis (UC). The aim of this study was to evaluate the performance of the AGA risk factors for risk stratification in UC and CD. METHODS: We included participants of 2 cohorts: the Ocean State Crohn's and Colitis Area Registry cohort and the Mayo Clinic cohort. Baseline clinical risk factors were extracted according to the AGA pathway. Our primary end point was defined as follows: (i) any inflammatory bowel disease related–hospitalization, (ii) any inflammatory bowel disease–related bowel surgery, or (iii) any progression of disease. We analyzed the association of the number of AGA risk factors with our end point. Statistical multivariable modeling was performed with Cox proportional hazards model. RESULTS: A total of 412 patients with CD were included. Comparing ≥3 risk factors with 0–1 risk factor, we found a significantly increased risk of complications in both the Ocean State Crohn's and Colitis Area Registry cohort (hazard ratio [HR] 2.75, 95% confidence interval 1.71–4.41) and Mayo Clinic cohort (HR 2.07, 95% confidence interval 1.11–3.84). Diagnosis at younger age (HR 2.07), perianal disease (HR 1.99), and B2/B3 behavior (HR 1.92) were significantly associated with disease complications. We did not observe a consistent association between number of risk factors nor any specific individual risk factors and risk of disease complications in the 265 patients with UC included. DISCUSSION: We found a significant association between the number of AGA risk factors and the risk of disease complication in CD; this association was not significant in UC. The presence of ≥ 3 risk factors in CD leads to the highest risk of complications. The AGA care pathway is a useful tool to stratify patients who are at higher risk of disease complications in patients with CD.
Preventing Small-for-size Syndrome in Living Donor Liver Transplantation: Guidelines From the ILTS-iLDLT-LTSI Consensus Conference
Aunés, Carmen Vinaixa, Mazzola, Alessandra , Alconchel, Felipe , Yoon, Young-In, Testa, Giuliano , Soin, Arvinder S., Pomposelli, James J. , Menon, Krishna , Kota, Venugopal, Abu‐Gazala, Samir , Rodríguez-Dávalos, Manuel I. , Rajalingam, Rajesh , Kapoor, Dharmesh, Kamath, Patrick S. , Sudhindran, Surendran, Vij, Vivek , Egawa, Hiroto , Lerut, Jan , Bröering, Dieter C. , Berenguer, Marina , Cattral, Mark S. , Clavien, Pierre‐Alain , Chen, Chao‐Long, Shah, Samir, Zhu, Zhi‐Jun , Ascher, Nancy L. , Emond, Jean C. , Rela, Mohamed , Kamath, Patrick, Berenguer, Marina , Alconchel, Felipe , Hakeem, Abdul , Mathew, Johns Shaji , Yoon, Young-In, Selzner, Nazia , Sarin, Shiv Kumar , Lee, Kwang‐Woong , Goyal, Neerav , Durand, François , Jothimani, Dinesh , Sudhindran, Surendran, Yoshizumi, Tomoharu , Bhangui, Prashant , Rammohan, Ashwin

Mayo Clinic

Transplantation | August 28, 2023 | Volume: 107 | Issue: 10 | Pages: 2203-2215

10.1097/tp.0000000000004769 | PMID 37635285 Get It

Small-for-size syndrome (SFSS) is a well-recognized complication following liver transplantation (LT), with up to 20% developing this following living donor LT (LDLT). Preventing SFSS involves consideration of factors before the surgical procedure, including donor and recipient selection, and factors during the surgical procedure, including adequate outflow reconstruction, graft portal inflow modulation, and management of portosystemic shunts. International Liver Transplantation Society, International Living Donor Liver Transplantation Group, and Liver Transplant Society of India Consensus Conference was convened in January 2023 to develop recommendations for the prediction and management of SFSS in LDLT. The format of the conference was based on the Grading of Recommendations, Assessment, Development, and Evaluation system. International experts in this field were allocated to 4 working groups (diagnosis, prevention, anesthesia, and critical care considerations, and management of established SFSS). The working groups prepared evidence-based recommendations to answer-specific questions considering the currently available literature. The working group members, independent panel, and conference attendees served as jury to edit and confirm the final recommendations presented at the end of the conference by each working group separately. This report presents the final statements and evidence-based recommendations provided by working group 2 that can be implemented to prevent SFSS in LDLT patients.
Creation of an Inflammatory Bowel Disease Referral Pathway for Identifying Patients Who Would Benefit From Inflammatory Bowel Disease Specialist Consultation
Scott, Frank I. , Ehrlich, Orna , Wood, Dallas , Viator, Catherine, Rains, Carrie, DiMartino, Lisa , McArdle, J. Ardle , Barkoff, Lara, Caudle, Jennifer, Cheng, Jianfeng, Kinnucan, Jami , Persley, Kimberly M., Sariego, Jennifer, Shah, Samir A. , Heller, Caren, Rubin, David T , Scott, Frank I , Rains, Caroline B. , Adams, Gabrielle, Rubin, David T.

Mayo Clinic

Inflammatory Bowel Diseases | October 22, 2022 | Volume: 29 | Issue: 8 | Pages: 1177-1190

10.1093/ibd/izac216 | PMID 36271884 Get It

Abstract Background Recommendations regarding signs and symptoms that should prompt referral of patients with inflammatory bowel disease (IBD) to an IBD specialist for a consultation could serve to improve the quality of care for these patients. Our aim was to develop a consult care pathway consisting of clinical features related to IBD that should prompt appropriate consultation. Methods A scoping literature review was performed to identify clinical features that should prompt consultation with an IBD specialist. A panel of 11 experts was convened over 4 meetings to develop a consult care pathway using the RAND/UCLA Appropriateness Method. Items identified via scoping review were ranked and were divided into major and minor criteria. Additionally, a literature and panel review was conducted assessing potential barriers and facilitators to implementing the consult care pathway. Results Of 43 features assessed, 13 were included in the care pathway as major criteria and 15 were included as minor criteria. Experts agreed that stratification into major criteria and minor criteria was appropriate and that 1 major or 2 or more minor criteria should be required to consider consultation. The greatest barrier to implementation was considered to be organizational resource allocation, while endorsements by national gastroenterology and general medicine societies were considered to be the strongest facilitator. Conclusions This novel referral care pathway identifies key criteria that could be used to triage patients with IBD who would benefit from IBD specialist consultation. Future research will be required to validate these findings and assess the impact of implementing this pathway in routine IBD-related care.
The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Surgical Management of Ulcerative Colitis
Holubar, Stefan D. , Vogel, Jon D., Gaertner, Wolfgang B. , Davis, Bradley R. , Davis, Kurt G. , Mahadevan, Uma, Shah, Samir A. , Kane, Sunanda V. , Paquette, Ian M., Holubar, Stefan D , Lightner, Amy L. , Poylin, Vitaliy Y. , Steele, Scott R. , Feingold, Daniel L.

Mayo Clinic

Diseases of the Colon & Rectum | April 17, 2021 | Volume: 64 | Issue: 7 | Pages: 783-804

10.1097/dcr.0000000000002037 | PMID 33853087 Get It

The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Surgical Management of Crohn’s Disease
Lightner, Amy L., Vogel, Jon D., Keller, Deborah S. , Shah, Samir A. , Mahadevan, Uma, Kane, Sunanda V. , Paquette, Ian M., Lightner, Amy L. , Carmichael, Joseph C. , Steele, Scott R. , Feingold, Daniel L.

Mayo Clinic

Diseases of the Colon & Rectum | July 7, 2020 | Volume: 63 | Issue: 8 | Pages: 1028-1052

10.1097/dcr.0000000000001716 | PMID 32692069 Get It

Variation in Prevalence, Diagnostic Criteria, and Initial Management Options for Eosinophilic Gastrointestinal Diseases in the United States
Spergel, Jonathan M. , Book, Wendy , Mays, Elizabeth, Song, L, Shah, Samir S. , Bonis, Peter A, Talley, Nicholas J.

Mayo Clinic

Journal of Pediatric Gastroenterology and Nutrition | November 6, 2010 | Volume: 52 | Issue: 3 | Pages: 300-306

10.1097/mpg.0b013e3181eb5a9f | PMID 21057327 Get It

ABSTRACTObjectives:Variation in the prevalence of eosinophilic gastrointestinal diseases in different geographical regions has not been extensively studied. The aim of the present study was to define the regional and national prevalence of eosinophilic gastrointestinal diseases, and differences in practice approaches.Patients and Methods:We administered a survey electronically to members of the American College of Gastroenterology, the American Academy of Allergy, Asthma, and Immunology, and the North American Society Pediatric Gastroenterology, Hepatology, and Nutrition. Questions pertained to the number and proportion of patients seen with eosinophilic gastroenteritis or colitis and eosinophilic esophagitis (EoE), and methods used to diagnose and treat these conditions.Results:A total of 1836 physicians responded from 10,874 requests (17% response). Extrapolating responses from our US sample, we estimated an overall prevalence of 52 and 28/100,000 for EoE and eosinophilic gastroenteritis or colitis. The patient burden of EoE is higher in urban (0.58) and suburban (0.44) compared with rural settings (0.36, P < 0.0065), observations consistent with other allergic disorders. There was also increased prevalence in northeast region when calculated by prevalence per 100,000. There was considerable variability in criteria and initial treatment options used to diagnose EoE. Only one‐third of respondents reported using diagnostic criteria proposed in a 2007 consensus document. Seventy‐one and 35% of respondents reported treating some patients with EoE with a food elimination or elemental diet, respectively.Conclusions:EoE is diagnosed more often in northeastern states and urban areas. There is considerable variability in diagnostic criteria and initial treatment approach supporting the need for additional clinical trials and consensus development.